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Abstract
Background: Target specific antibodies are pivotal for the design of vaccines, immunodiagnostic tests, studies on
proteomics for cancer biomarker discovery, identification of protein-DNA and other interactions, and small and
large biochemical assays. Therefore, it is important to understand the properties of protein sequences that are
important for antigenicity and to identify small peptide epitopes and large regions in the linear sequence of the
proteins whose utilization result in specific antibodies.
Results: Our analysis using protein properties suggested that sequence composition combined with evolutionary
information and predicted secondary structure, as well as solvent accessibility is sufficient to predict successful
peptide epitopes. The antigenicity and the specificity in immune response were also found to depend on the
epitope length. We trained the B-Cell Epitope Oracle (BEOracle), a support vector machine (SVM) classifier, for the
identification of continuous B-Cell epitopes with these protein properties as learning features. The BEOracle
achieved an F1-measure of 81.37% on a large validation set. The BEOracle classifier outperformed the classical
methods based on propensity and sophisticated methods like BCPred and Bepipred for B-Cell epitope prediction.
The BEOracle classifier also identified peptides for the ChIP-grade antibodies from the modENCODE/ENCODE
projects with 96.88% accuracy. High BEOracle score for peptides showed some correlation with the antibody
intensity on Immunofluorescence studies done on fly embryos. Finally, a second SVM classifier, the B-Cell Region
Oracle (BROracle) was trained with the BEOracle scores as features to predict the performance of antibodies
generated with large protein regions with high accuracy. The BROracle classifier achieved accuracies of 75.26-
63.88% on a validation set with immunofluorescence, immunohistochemistry, protein arrays and western blot
results from Protein Atlas database.
Conclusions: Together our results suggest that antigenicity is a local property of the protein sequences and that
protein sequence properties of composition, secondary structure, solvent accessibility and evolutionary
conservation are the determinants of antigenicity and specificity in immune response. Moreover, specificity in
immune response could also be accurately predicted for large protein regions without the knowledge of the
protein tertiary structure or the presence of discontinuous epitopes. The dataset prepared in this work and the
classifier models are available for download at https://sites.google.com/site/oracleclassifiers/.
Background
The humoral immune response is based on the ability of
antibodies to recognize and bind to epitopes on the sur-
face of antigens with high specificity. It is believed that
most protein epitopes are composed of different parts of
the polypeptide chain that are brought into spatial
proximity by the folding of the protein or discontinuous.
However, for approximately 10% of the epitopes, the
corresponding antibodies are cross-reactive with a linear
peptide fragment of the epitope [1]. These epitopes are
termed linear or continuous and are composed of a sin-
gle stretch of the polypeptide chain.
In many cases it is difficult to obtain a pure prepara-
tion of the protein of interest for immunization pur-
poses. The traditional cloning of the proteins or
experimental peptide scanning approach is clearly not
feasible on a genomic scale. However, to raise antibodies
it is not necessary to present the complete protein but
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be generated by immunization of animals with a peptide
if the peptide is well chosen and presents an effective
continuous epitope of the protein. The continuous B-
cell epitopes play a vital role in the development of pep-
tide vaccines, in diagnosis of diseases, and for allergy
research. The specific interactions between antibodies
generated against the continuous epitopes are also
exploited extensively in biochemical and high-through-
put assays. The ENCODE [2] and the modENCODE [3]
projects aim to profile protein-DNA interactions for all
transcription factors and DNA associated proteins for
Human and for model organisms like Drosophila mela-
nogaster and Caenorhabditis elegans using the factor
specific antibodies. This has increased the demand for
good antibodies at the whole genome level.
The computational methods can be cost effective and
reliable for predicting linear B-cell epitopes and can
g u i d eag e n o m ew i d es e a r c hf o r antigenic B-cell epi-
topes. Therefore, a lot of research has been devoted in
the past for identifying continuous B-cell epitopes from
the protein sequences. The classical approach of epitope
prediction is to utilize the amino acid propensity scales
describing properties like hydrophobicity [4], hydrophili-
city [5], flexibility/mobility [6], surface accessibility [7],
polarity [8,9], turns [10], and antigenicity [11]. The first
propensity scale method for predicting linear B-cell epi-
topes was introduced by Hopp and Woods [12] and uti-
lized the Levitt hydorophilicity scale [13] to assign a
propensity value to each amino acid. PREDITOP [10],
PEOPLE [14], BEPITOPE [15], and BcePred [16] pre-
dicted linear B-cell epitopes based on combinations of
physico-chemical properties as opposed to the propen-
sity measures that rely on individual properties. The
BcePred method obtained the best specificity of 56%
and sensitivity of 61% [16]. Blythe and Flower assessed
484 amino acid propensity scales in combination with
ranges of plotting parameters and found that even the
best set of scales and parameters perform only margin-
ally better than random [17]. This led researchers to
combine propensity scales with machine learning meth-
ods to improve the performance. The BepiPred [1]
method combined the Parker hydorophilicity scale [5]
with a Hidden Markov Model (HMM) and demon-
strated a slight but statistically significant improvement
in the classification performance compared to the per-
formance of the propensity scale based methods. Chen
et al. [18] developed an amino acid pair (AAP) antigeni-
city scale that assigns to each possible pair of amino
acids, a propensity value. Their support vector machine
(SVM) classifiers trained using amino acid pair (AAP)
propensity derived features outperformed SVM classi-
fiers trained using amino acid propensity derived fea-
tures [18].
Recently, several researchers have explored various
machine learning methods with learning examples for
predicting linear B-cell epitopes using amino acid
sequence information. The ABCPred [19] method use
recurrent artificial neural networks for predicting linear
B-cell epitopes. Söllner and Mayer [20] represent each
peptide features derived from a variety of propensity
scales, neighborhood matrices, and respective probability
and likelihood values and attained an accuracy of 72%.
T h eB C P r e da n dF B C P r e d[ 2 1 ]m e t h o d sp r e d i c tl i n e a r
B-cell epitopes and flexible length linear B-cell epitopes
(respectively) using SVM classifiers that use string ker-
nels. The COBEpro [22] method use a two-step proce-
dure for predicting linear B-cell epitopes. In the first
step, an SVM classifier is used to assign scores to frag-
ments of the query antigen. In the second step, a predic-
tion score is associated with each residue in the query
antigen based on the SVM scores for the peptide frag-
ments. Many methods utilizing three-dimensional (3D)
structure to predict discontinuous epitopes are also
available [23,24]. We refer readers to a recent review by
El-Manzalawy and Honavar [25] for a more detailed
discussion.
There are several problems common to recently devel-
oped machine-learning methods. These methods have
utilized only a limited amount of positive learning
examples. Some of these methods have utilized negative
learning examples derived from random protein frag-
ments. These negative training examples may harbor
genuine B-cell epitopes and affect the training procedure
and result in poor classification performance. Moreover,
none of the published work has systematically combined
and compared the performance of various structural
properties and evolutionary information in bringing
about good classification performance. Finally, most
methods have utilized large peptide lengths (e.g. 20) in
their benchmarking experiments. Predicting protein epi-
topes within the length range of 7-15 is important as
peptide in this length range are easy to synthesize
experimentally and well-chosen peptides could generate
specific antibodies. The effect of peptide length on the
classification performance has not been checked system-
atically. It is worth noting that these methods have
failed to achieve accuracy > 75% and AUC > 0.75.
To overcome these limitations, we have generated a
large non-redundant training set of B-cell epitopes with
b o t ht h ep o s i t i v ea n dt h en e g ative learning examples.
This dataset was prepared by combining data from the
Immune epitope database [26], the BCIPEP database
[27] and the AntiJen database [28,29] that has informa-
tion on small peptide epitope antigenicity and specificity
in immune response. We have created and leveraged the
computational capabilities of Open Life Science Gateway
(OLSGW; Wu et al. Submitted; see Methods) to
Wang et al. BMC Bioinformatics 2011, 12:251
http://www.biomedcentral.com/1471-2105/12/251
Page 2 of 13exhaustively predict structural properties for sequences
containing epitopes. We have checked contributions of
different protein structural properties including first and
higher order composition, evolutionary conservation
information, compositional and per residues probabil-
ities for secondary structure, solvent accessibility, disor-
der, and low-complexity. We show that the utilization of
negative examples and increasing the training set size
contribute to the improved classification performance.
However, the set of learning features have a definite
impact on the learning process. We have also checked
the effect of epitope length on the classification
performance.
We introduce the B-cell epitope oracle (BEOracle), a
SVM classifier that integrates different types of informa-
tion that was provided as learning features to the classi-
fier and validate the classifier on multiple validation
sets. A large test set, a list of 32 chromatin immunopre-
cipitation (ChIP) grade antibodies and 10 HDAC antibo-
dies with known epitope sequences were utilized as
validation sets. Moreover, we checked whether BEOracle
scores for HDAC peptides antibodies correlated with
the intensity of fluorescence in immunofluorescence
experiments on the Drosophila melanogaster embryos.
Finally, a second SVM classifier, B-cell region oracle
(BROracle) that utilizes the BEOracle scores as learning
features, was trained to predict specificity of antibodies
produced after immunization with large protein
domains. This is first such attempt in our knowledge.
Validation information for immunofluorescence (IF),
western blot (WB), immunohistochemistry (IHC) and
protein array (PA) data from Protein Atlas database was
used to assess performance of BROracle.
Results
We have carried out more than 150 SVM classification
experiments with a large learning set that provides both
positive and negative learning examples for the training
o ft h eB E O r a c l ea n dt h eB R O r a c l ec l a s s i f i e r s( F i g u r e1 ) .
Each classification experiment includes a 5-fold cross
validation on the training set while varying the feature-
sets, the SVM kernels and the peptide lengths. The
learning features extracted from training examples pro-
vided to the classifier protein composition information
in terms of the n-grams, evolutionary information
encoded in the position specific scoring matrix (PSSM),
and the structural information like secondary structure,
solvent accessibility, disorder, and low-complexity
assignments predicted using the state-of-the-art bioin-
formatics algorithms. The BEOracle and the BROracle
classification performances were validated on multiple
validation sets. See Methods for details on learning sets
and feature extraction procedure.
Combining sequence features improve classification
performance
Our experiments suggest that the n-gram features pro-
v i d i n gi n f o r m a t i o no nt h ep r o t e i nc o m p o s i t i o nw i t h
length 15 provides good classification performance and
generalizes well (Figure 2). The classification perfor-
mance calculated as the F1-measure decreases from
73.95% to 60.32% as n-gram number decreases from 5
to 1 (see Methods). Using position based encoding, nor-
malizing the n-grams with background frequency of
amino acids in Uniprot database or using physico-che-
mical scales for SVM learning did not provide good
classification performance (Additional file 1 Section 6).
Figure 1 An overview of the machine learning and validation procedures for BEOracle and BROracle SVM classifiers.
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provides satisfactory classification performance. On the
other hand, combining appropriate features substantively
improves the classification accuracy and the F1-measure
(Figure 2). The combination of n-gram features, evolu-
tionary information, secondary structure and solvent
accessibility information resulted in the best classifica-
tion performance (best feature set; Figure 2). The best 3
classifiers in the 5-fold cross validation studies utilized
the best feature set with polynomial kernels of degrees 2
and 3, and the radial basis function kernel (RBF),
respectively. Adding other structural features such as
disorder and low complexity information did not
improve classification performance (Figure 2).
The best classifier achieved an accuracy of 82.16% and
the F1-measure of 81.37% to the average accuracy of
59.51% and the average F1-measure of 59.08% when
using only one type of features. The polynomial kernel of
degree 3 has the highest area under the curve (AUC) of
0.88 followed by the polynomial kernel of degree 2 with
the AUC of 0.87 and the RBF kernel with the AUC of
0.86 (Figure 3A). The BCpred [18] and Bepipred [1]
methods follow with AUC = 0.70 and AUC = 0.65,
respectively. The identification of epitopes using various
amino acid propensity scales is only marginally better
than the random model as mentioned above. The classifi-
cation performance of our SVM classifier(s) is a marked
improvement on these and other published methods.
Utilization of negative training examples improve the
classification performance
To assess the contribution of negative learning examples
on the SVM classification performance; we trained our
best SVM classifier with a dataset prepared by El-Man-
zalawy et al [21] and the best feature set. The El-Manza-
lawy dataset contains 777 non-redundant positive
Figure 2 The SVM classifier performance on single features and on various feature combinations. N-gram features (n = 1..5) provide
compositional information, secondary structure (ss2), solvent accessibility (acc), disorder (vsl2) and low-complexity features (seg) provide
structural information, and positional specific similarity matrix (pssm) that provides evolutionary information, are used in different combination to
identify a set of features that can provide best classification performance.
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equal number of negative learning examples randomly
extracted from the sequences in the Swissprot database.
The SVM classifier trained on the random negative
examples achieved the AUC of 0.7813 (F1-measure of
73.90%) at the epitope length of 12 and the AUC of
0.7881 (F1-measure of 74.49%) at the epitope length of
14 (Figure 3B). This is a small yet significant decrease in
classification performance compared to the AUC of
0.7951 (F1-measure of 75.92%) and 0.8019 (F1-measure
of 76.12%) obtained when the classifier was trained with
actual negative examples at these lengths (see Additional
File 1, Section 8).
The training of our SVM classifier on this dataset has
also allowed for a more direct comparison of the predic-
tion performance of our classifier with the BCPred method
(Figure 3B). The BCPred classifier achieved the AUC of
0.7135 and 0.7145 at lengths of 12 and 14 on the test set
prepared by us, which is significantly less than the AUC
achieved by our classifier mentioned in the previous
paragraph. Thus, our classifier even when trained on El-
Manzalawy dataset clearly outperforms BCPred (Figure
3B). This result also supports the conclusion that utiliza-
tion of the best feature set improves the classification per-
formance (see Additional File 1, Section 8).
Improvement in the classification performance is not
solely dependent on the size of the training set
Compared to other published methods we have created
a large learning set that provides the SVM classifier
with both the positive and the negative learning exam-
ples. It is possible that this large learning set size is
solely responsible for the improved classification perfor-
mance. Therefore, we utilized 10% (392 positive and 392
negative examples) increments of our training set with
epitope length 15 and the best feature set to study the
performance improvement with increase in the learning
set (Figure 3C). The F1-measure decreases from 81.37%
to 71.31% with the decrease in learning examples and
the AUC decreases from 0.88% to 0.75%. However, even
Figure 3 Comparision of classifier performance:(A) performance of the best classifier at length 15 compared to other methods, (B) impact of
negative examples on SVM learning and comparison of the classifier performance with BCPred at lengths 12 and 14, (C) Effect the of training
dataset size on the classification performance and (D) comparision of best classifiers at different epitope lengths.
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less than the training set size of BCPred or Bepipred,
the SVM classifier trained on the best feature set outper-
forms these methods.
Classification performance is dependent on the epitope
length
The epitope length of 15 utilized in the classification
experiments above is less than those utilized by other
methods. Moreover, epitope length could affect the epi-
tope specificity and therefore the classification perfor-
mance. Surprisingly, effect of epitope length on the
classification performance has not been studied systema-
tically in previous works. Therefore we checked the clas-
sification performance from length 7 to 15, the range in
which peptides can be synthesized relatively easily (Fig-
ure 3D). We found that the F1-measure decreased from
81.37% to 73.69% and the AUC decreased from 0.88 to
0 . 7 6w i t ht h ed e c r e a s ei nt h ee p i t o p el e n g t h .H o w e v e r ,
even when training with the epitope length of 7, which
is less than the epitope length utilized by BCPred and
Bepipred during the training, our SVM classifier outper-
formed those methods. Therefore, we believe that the
learning features in the best set indeed play a big role in
the improved classification performance.
Identification of the B-cell epitopes from large protein
sequences
We developed a scanning procedure to identify the B-
cell epitopes from large protein sequences with high
confidence. The scanning procedure that we developed
takes a desired peptide length, a step length and utilizes
features extracted for this peptide to give it a SVM
score. The scanning procedure obtained the F1-measure
of 78.44% and the AUC of 0.83 with the peptide length
15, the step length of 1 and the best feature set.W e
term this predictor B-Cell epitope oracle (BEOracle).
Validation of the BEOracle classification performance
For validating the BEOracle performance in identifying
epitopes that could result in ChIP-grade antibodies, a
list of 32 antibodies with known peptide epitopes was
compiled from the ENCODE [2] and the modENCODE
[3] project wiki pages. These antibodies have been used
for identifying genome-wide binding profiles of tran-
scription factors and DNA associated proteins by micro-
arrays or next generation sequencing. We compared the
BEOracle performance with the BCPRED and the
Bepipred methods at specificity of 80%. The scanning
procedure provided positive scores indicating good epi-
t o p e sf o r3 1o u to ft h e3 2p e p t i d e sa n da c h i e v e da n
accuracy of 96.88%. The remaining 1 got the score of
zero and none got the negative score that indicated
poor epitopes. The BCPRED algorithm provides positive
scores for 18 out of 32 (56.25%) while the BEPIPRED
model provides positive scores for 17 out of 32 epitopes
(53.12%; Table 1, 2).
Another validation set of 10 HDAC antibodies with
known epitope sequences was also used to validate
BEOracle performance. The peptides for all HDAC anti-
bodies obtained positive BEOracle scores during the
Table 1 Comparision of prediction performance of
BEOracle with BCPred and Bepipred on peptide
antibodies used in ENCODE project
ENCODE BEOracle BCPred Bepipred
BRF2-2 1 1 1
RPC155 1 0 0
BRF2-1 1 0 0
NONO 1 1 1
BDP1 1 0 0
BRF1 1 0 0
Table 2 Comparision of prediction performance of
BEOracle with BCPred and Bepipred on peptide
antibodies used in modENCODE project
modENCODE BEOracle BCPred Bepipred
Rabbit anti-Stat92E 1 1 0
HDAC6-497 1 1 0
HDAC3-499 1 0 0
HDAC1-501 1 0 1
Egg (Kang) 1 1 0
chinmo 70850 1 0 1
CP190 1 0 0
CTCF-C 1 0 0
sens 1 1 1
HP1 wa191 1 1 0
CTCF-N 0 1 1
HP1 wa192 1 1 1
HDAC4a-492 1 0 1
HA 1 0 1
HDAC1-500 1 1 1
HP1c (Henikoff) 1 1 0
HDAC6-496 1 1 1
HDAC3-498 1 0 1
HDAC11-495 1 1 1
JL00012_DPY28 1 1 1
POF 1 1 1
BEAF-32 1 0 0
HDAC11-494 1 1 0
HDAC4a-493 1 0 0
anti-HTZ-1 1 1 1
HP1b (Henikoff) 1 1 1
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We carried out immunofluorescence experiments for
these antibodies on the Drosophila melanogaster
embryos and annotated fluorescence intensity into four
groups very good, good, low intensity and not good IF
(Table 3). We sorted BEOracle scores from high to low
and compared the correlation between the BEOracle
score and the fluorescence intensity in a blind testing
set up. There are three antibodies with “Very good”
fluorescence in the top 5 versus only one in the bottom
5. Moreover, only 1 antibody in the top 5 has “low
intensity” and no antibody has “n o tg o o di n t e n s i t y ”.
Therefore, there is some evidence of correlation of
fluorescence intensity with the BEOracle score.
Although, a larger testing set is required to substantiate
this claim (Table 3, Figure 4). Based on the BEOracle
performance on these two independent validation sets,
we can conclude that the classifier identifies B-cell epi-
topes from the linear protein sequences that can create
antibodies with high specificity.
Local information allows for the prediction of specificity
in immune response for large protein regions
Distributional analysis of scan scores for 4344 positive
and 4344 negative training examples extended to the
length 100 showed that the positive learning examples
have higher frequency of positive BEOracle scores than
the negative learning examples (p-value 2.2e-16; Kolmo-
gorov Smirnov test; Figure 5A). Therefore, these
extended regions containing positive and negative B-cell
epitopes could be utilized to train a classifier for pre-
dicting the specificity in immune response for large pro-
tein regions or domains. However, it should be noted
that the negative learning set here might contain some
genuine B-cell epitopes. A second set of classifiers with
different SVM kernels were trained using the BEOracle
SVM scanning scores as learning features. The SVM
classifier with the radial basis function kernel achieved
an F1-measure of 78.45% in 5-fold cross-validation. We
term this classifier the B-cell region oracle (BROracle).
Table 3 Correlation of IF experimental results on HDAC
antibody to SVM scores
Antibody_Name SVM_Score Comments
HDAC4a-493 0.879548 Very Good
HDAC11-494 0.767461 Very Good
HDAC3-498 0.698287 Low intensity
HDAC1-500 0.602691 Very Good
HDAC11-495 0.535022 Good
HDAC3-499 0.533935 Low intensity
HDAC4a-492 0.5196 Not good IF
HDAC6-497 0.35699 Low intensity
HDAC6-496 0.184187 Good
HDAC1-501 0.167799 Very Good
Figure 4 Immunofluorescence of HDAC antibodies on Drosophila melanogaster embryos. Experimental intensities for antibodies A-L
ordered as in Table 3. A-B and C-D show images for the same antibodies.
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76.00% and the ROC area of 0.8127 on the validation
set (Figure 5B). The BROracle classifier has been trained
such that it can handle protein regions of any length.
Please see Additional File 1 for the description of the
training algorithm.
Validation of the BROracle classification performance
The classification performance of the BROracle was
further validated on 600 Human protein regions of vary-
ing lengths extracted from the Human Protein Atlas
database [30]. Immune response specificity information
in terms of IF, WB, IHC and PA experiment results is
available for these regions. The BROracle classifier
achieved the highest accuracy of 76.26% for the IF and
the lowest accuracy of 63.88% for the WB experiments
(Figure 5B; Table 4). Therefore we can conclude that
local information on antigenicity and specificity, avail-
able as BEOracle scores, can predict specificity in
immune response for large protein regions. We can also
conclude that specificity in immune response on large
regions can be predicted without identifying discontinu-
ous/conformational epitopes that may be present in
these regions.
Figure 5 E O r a c l ep e p t i d es c o r e sa r ep r e d i c t i v eo ft h es p e c i f icity in immune response for large protgein regions.( A )B E O r a c l es c o r e
distribution for positive and negative training examples extended to length 100. (B) Validation of BROracle classifier performance on protein atlas
data: IF, IHC, PA, WB and ROC curves of BROracle on test set vs Random model.
Wang et al. BMC Bioinformatics 2011, 12:251
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SVMs are widely used classifiers while performing
machine learning in settings with high-dimensional fea-
ture space. They have been shown to outperform other
classification methods in different learning tasks. SVMs
have been used in many published studies for the B-cell
epitope identification [18,21,22]. The BEOracle classifier
described in this work is also an SVM classifier and pro-
vides significant improvement in the B-cell epitope pre-
diction task, as attested on a large test set and multiple
biological validation sets.
It is possible that other classification algorithms
trained on the feature sets described in this work may
outperform the BEOracle classifier. Instead of looking
for the best classification algorithm, we have exhaus-
tively surveyed the structural properties of proteins at
the global and the residual level and identified the best
sets of properties that provide improved classification
performance. The novelty of this work lies in the sys-
tematic feature extraction and integration that provides
information on determinants of antigenicity in protein
sequences that could result on highly specific antibodies.
We will compare the classification performance of dif-
ferent classification methods with feature sets described
here in future. The BEOracle classifier requires the
structural and evolutionary information from other soft-
ware like BLASTP, PSIPRED, and ACCPRO20 as input.
These steps are computationally intensive when per-
formed on large data sets or on a whole proteome scale.
The OLSGW scientific gateway on the TeraGrid pro-
vided the required computing power for this analysis.
Our experiments suggested that the determinants of
antigenicity are largely compositional rather than posi-
tional as n-grams, secondary structure, solvent accessi-
bility and evolutionary information were presented to
t h ec l a s s i f i e rl a r g e l ya sc o m p o sitional features extracted
from positive and negative learning examples. Other
encodings and feature sets do not work as well. The
BEOracle classifier utilizing features from only these
properties provided an impressive F1-measure of 81.37%
on a large test set. The classification performance
improves with the increase in the peptide length as it
provides more accurate estimation of epitope composi-
tion and its neighborhood. The amino acid neighbor-
hood and evolutionary information is routinely utilized
for accurate prediction of secondary structure, solvent
accessibility and other structural properties. The
PSIPRED method utilizes the PSSM matrices generated
by the PSI-BLAST and the ACCPRO utilizes both the
secondary structure predicted by the PSIPRED and the
PSSM matrices generated by the PSI-BLAST. Even then
features derived from these three contributed distinctly
in improving the prediction performance. We saw a
marked increase in the classification performance when
20-state solvent accessibility was used in the training
instead of the 2-state solvent accessibility. Therefore,
more granular secondary structural information may
also improve the classification performance.
For any classifier, it is understandable to have some
loss of prediction power due to composition of learning
sets and a theoretical limit in prediction performance.
For example it is estimated that secondary structure
prediction possibly has an upper limit of 90% [31]. Dur-
ing the training of the BEOracle classifier the best set of
learning features are selected from an exhaustive list of
possible features that can be predicted. However, the
learning examples were compiled from different data-
bases with entries varying in quality and epitopes identi-
fied using different experimental methods. Moreover,
the various bioinformatics methods used to predict fea-
tures have their own error rates. Therefore, F1-measure
of 81.37% and the AUC of 0.88 of the BEOracle classi-
fier are indeed impressive and perhaps suggestive of the
fact that our work has identified determinants of antige-
nicity and specificity in immune response.
This assertion is further corroborated by the identifi-
cation of peptides epitopes for 32 ChIP-grade antibodies,
and 10 HDAC antibodies with > 96% accuracy by the
BEOracle classifier and by the performance of the
BROracle classifier that successfully predict highly anti-
genic regions from protein sequences. The BROracle
classifier only utilizes only BEOracle scores as features.
It doesn’t utilize any three-dimensional structure infor-
mation and is unaware of any conformational epitopes
t h a tm a yb ep r e s e n ti nt h o s el a r g er e g i o n s .Y e t ,t h e
BROracle classifier can successfully identify those
regions on a validation set with four different assay
types for Human proteins extracted from the Protein
Atlas database. Therefore, we believe that composition,
secondary structure, solvent accessibility and evolution-
ary information are indeed the determinants of antigeni-
city and specificity in immune response as they can be
Table 4 Validation of classifier performance on Protein Atlas domains
Validation Pos-set Neg-set ACC TPR FPR Prec Recall
IF 130 (Support) 60 (Non-support) 75.26% 80.29% 37.73% 80.15% 84.50%
IHC 247 (High) 77 (Very low) 71.60% 81.12% 60% 81.78% 81.12%
PA 480 (1) 80 (2) 73.93% 87.11% 80% 81.67% 87.11%
WB 258 (1~2) 159 (6~7) 63.88% 67.73% 48.93% 82.17% 67.73%
Wang et al. BMC Bioinformatics 2011, 12:251
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response for small epitopes and for large regions.
Further improvements in the B-cell epitope prediction
task can be achieved by utilizing other features. For
example, knowledge of the 3-dimensional structures
(3D) of proteins will provide accurate information on
secondary structure and solvent accessibilities. Addi-
tional structural features like H-bonding and residue
packing can be derived only from the 3D structures.
Functional information like post-translational modifica-
tion (e.g. known and predicted phosphorylation), pro-
tein-protein and peptide-protein interaction interfaces
and Gene Ontology categories can be utilized as fea-
tures. Other information on reactivity, presence of
homologous sequences in the genome of antibody
source/host species can also be utilized as features. Uti-
lizing these features for predicting specificity in immune
response could lead to improved performance for both
continuous and perhaps discontinuous B-cell epitopes.
Conclusions
Our results indicate that the features derived from epi-
tope composition, secondary structure, solvent accessi-
bility and evolutionary conservation can be used to
identify linear B-cell epitopes with a very high accuracy.
They also indicate that the determinants of antigenicity
and specificity in immune response are largely composi-
tional rather than positional since the learning examples
for the best classifier were encoded as compositional
features. The BEOracle classifier achieved an F1-mea-
sure of 81.37% and > 96% accuracy in identifying pep-
tides for ChIP-grade antibodies for ENCODE and
modENCODE projects.
The BROracle classifier predicts specificity in immune
response for large protein regions. This task has not
been addressed before. The BROracle classifier utilizes
BEOracle scores as features and therefore predicts using
the information from local features only. The BROracle
classifier achieved accuracies of 75.26-63.88% on a vali-
dation set with immunofluorescence, immunohisto-
chemistry, protein arrays and western blot results
obtained from the Protein Atlas database.
Together these results suggest that immunogenicity is
a local property of the protein sequences and immune
response obtained from the large protein regions could
be accurately predicted using local information. The
knowledge about protein tertiary structure or presence
of discontinuous epitopes is not required for predicting
immune response obtained from large protein regions.
The dataset prepared in this work and the classifier
models are available for download at https://sites.google.
com/site/oracleclassifiers/.
Methods
Non-redundant Dataset
We have prepared a large dataset containing positive
and negative training examples by combining entries
from immune epitope database (IEDB), BCIPEP and
AntiJen databases. We parsed these databases and
matched equivalent entry fields (Additional File 1, Table
S1). We extended these epitope sequences equally on
both the sides to get epitopes of a final length of 100
amino acids using the Uniprot identifiers associated
with them. The redundant peptides were removed from
this set as the presence of redundant examples in the
learning set could provide misleading results. The final
dataset contain 6581 positive and 9353 negative epitope
examples. The extended sequences allowed for an accu-
rate prediction of structural properties for the epitope
sequences as well as getting uniform length peptides.
Open Life Science Gateway for predicting protein
structural properties
We have developed and utilized the Open Life Science
Gateway (OLSGW; Wu et al, under review) for predict-
ing the structural properties of protein sequences.
OLSGW is a science gateway designed to rapidly deploy
and offer most commonly used bioinformatics software
and community databases, as web based services in a
standalone or a workflow based formats on the front
end while interacting with the TeraGrid resources
through reliable middleware for computing. OLSGW
makes a vast amount of computing resources at the
Argonne National Laboratory and 11 other partner sites
freely available for solving complex biological problems
without exposing users to the complexity of Grid com-
puting. OLSGW webportal is available at (http://gw25.
quarry.iu.teragrid.org:8080/gridsphere/gridsphere).
The current version of the OLSGW offers software for
sensitive sequence database searches (PSI-BLAST [32]
and HMMER [33]), multiple sequence alignments
(CLUSTALW [34] and MUSCLE [35]), secondary struc-
ture prediction (PSIPRED [36]), solvent accessibility pre-
diction (ACCPRO [37]), disorder prediction (VSL2 [38]),
3-dimensional homology modeling (MODELLER [39]),
and identification of a variety of protein signatures
(Interpro [40]) including sequence and structural
domains, signal peptide, transmembrane regions and
low-complexity regions. After a quick and automated
registration process, the OLSGW web portal allows sub-
mission of a single or multiple query protein sequences
in FASTA format. OLSGW searches for available com-
puting nodes on the TeraGrid partner sites, submits the
job on an appropriate queuing system, monitors them in
real time for completion and resubmits failed jobs. We
Wang et al. BMC Bioinformatics 2011, 12:251
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ondary structure, solvent accessibility, disorder and low
complexity information for more than 18,000 sequences
that belong to the training and the validation sets.
These calculation required more than 1700 hours or 28
days woth of CPU time. It was finished under 24 hours
by the means of the TeraGrid resources that was facili-
tated by the OLSGW.
Feature Calculation and Extraction
An exhaustive prediction of structural properties was
carried out using well-known bioinformatics software.
We extracted features providing evolutionary, structural
and compositional information to the classifier. See
Additional File 1 for examples of possible feature space
for proteins and different ways of encoding them. Here
we describe encoding for only those features that were
worth reporting in the work described here. For each
learning example PSI-BLAST [41] was run for 3 itera-
tions and a p-value cutoff of 1e-03 on nrfilt (filtered non
redundant protein sequence database from the NCBI)
database to generate the PSSM that provides evolution-
ary conservation information for each position of the
query sequence. The nrfilt database is available for
download with the PSIPRED package [36]. For each
amino acid the three-state secondary structure was pre-
dicted with the PSIPRED package associating probability
of being in helix, beta-strand or coil to them. The
twenty-state solvent accessibility was predicted with
ACCpro20 [37] providing probability of being accessible
to each amino acid. The two state disorder was pre-
dicted with the VSL2 algorithm [38] assigning probabil-
ity of being in disordered state to each amino acid. The
low complexity was predicted with the seg algorithm
[42]. The compositional information (e.g. percentage of
amino acids in helix) was calculated for each structural
feature for the original (non-extended) epitopes.
We utilized a total of 53633 learning features combin-
ing different types of information. N-varying from 1 to 5
provided the SVM with 20, 230, 1770, 10625 and 53129
features with the increasing number of n. They provide
the SVM with compositional information. For each epi-
tope we utilized evolutionary conservation information
from the PSI-BLAST generated PSSM file columns 21
to 40. Secondary structure contributes with 20*3+3 fea-
tures. The first 20 features provide the average of 3-
state prediction scores for each amino acid present in
the peptide. The last 3 features provide composition of
the peptide in terms of 3 assigned states from PSIPRED
output. 20-state solvent accessibility and disorder contri-
butes 20 features each in the way similar to the second-
ary structure. The low complexity prediction contributes
one feature for the whole epitope. The learning features
were scaled using svm-scale function in the libsvm [43]
to make them comparable to each other and provided
as input to the SVM classifier. The feature extraction
p r o c e d u r ef o rt h eB R O r a c l ec l a s s i f i e ri sd e s c r i b e di n
Additional File 1.
Classification Experiments and comparison with other
methods
We have carried out SVM classification experiment for
5 different lengths 7, 9, 11, 13, and 15, and 5 different
kernel functions including linear, polynomial kernels of
degrees 2 and 3, radial basis function (RBF), and sig-
moid for each featureset. The classification parameters
like F1-measure, precision, recall and accuracy reported
for the training set are sum of the 5-fold cross valida-
tion. Each partition of our dataset had 748 positive and
negative learning as well as test examples. The SVM
light
package [44] implementing support vector machines
with fast optimization algorithm and multiple kernel
functions was used for classification experiments. Dur-
ing the learning phase the SVM algorithm requires
labeled positive and negative learning examples as fea-
tures. Once a model is trained, test examples are read
and a score is given to each example. In this work, test
examples with scores greater than zero are considered
peptides that could be good B-cell epitopes and exam-
ples with scores less than zero are considered peptides
that wouldn’t be good B-cell Epitopes. We compared
classification performance of our best classifier with
BCEPRED that is based on propensity scales, BCPred
that utilizes an SVM based classifier [21] and Bepipred
[1] that utilizes a hidden markov model. The BCEPRED
method implements a total of seven classical propensity
scales that utilize protein physicochemical properties
like hydrophilicity [5], flexibility [45], accessibility [7],
turns [46], antigenicity [11], and polarity [8,9]. More
information can be found on http://www.imtech.res.in/
raghava/bcepred/bcepred_algorithm.html.
Datasets for Biological Validation
We validated the BEOracle classifier performance in
three different ways: 1) on a large test set, 2) using a list
of peptides that were used in generating antibodies for
carry out chromatin immunoprecipitation experiments
as a part of ENCODE and modENCODE projects and
3) a set of HDAC antibodies for which Immunofluores-
cence data was generated on Drosophila melanogaster
embryos as a part of the modENCODE project.
For the validation of the BROracle classifier, a large
test set, and 600 protein regions extracted from the Pro-
tein Atlas database are available [30]. These 600 protein
regions have assay quality scores for immunofluorescene
(IF; support vs. non-support), immunohistochemistry
(IHC; High vs. very low), western blot (WB; 1-2 vs. 6-7)
and protein array (PA; 1 vs 2).
Wang et al. BMC Bioinformatics 2011, 12:251
http://www.biomedcentral.com/1471-2105/12/251
Page 11 of 13Additional material
Additional file 1: supporting material to the main manuscript.
contains supplementary text, figures and tables
Abbreviations
BEOracle: B-Cell Epitope Oracle; SVM: support vector machine; BROracle: B-
Cell Region Oracle; ENCODE: Encyclopedia of DNA elements; modENCODE:
model organism of Encyclopedia of DNA elements; HMM: hidden markov
model; OLSGW: open life science gateway; RBF: radial basis function kernel;
AUC: area under curve; IF: immunofluorescence; WB: western blot; IHC:
immunohistochemistry; PA: protein array.
Acknowledgements
We would like to thank the members of Li lab for their helpful suggestions,
curators of BCIPEP, AntiJen, IEDB and Protein Atlas databases for curating
very high quality datasets and making them publicly accessible, and the
creators of publicly available SVM
light and libsvm softwares.
Part of the work was supported by the modENCODE grant U01 HG004264-
04 awarded to Kevin P White, NIH grant R01 GM077122 awarded to Cheng
Li, State Key Laboratory of Software Development Environment Funding No.
SKLSDE-2009ZX-12 to Wenjun Wu and the Claudia Adams Barr award to
Parantu K Shah.
Author details
1Department of Biostatistics and Computational Biology, Dana-Farber Cancer
Institute & Harvard School of Public Health, Boston 02115 MA, USA.
2State
Key Laboratory of Software Development Environment, Beihang University,
Beijing, 100191, China.
3Institute for Genomics and Systems Biology, The
University of Chicago, Chicago 60637 IL, USA.
Authors’ contributions
YW carried out the SVM classification experiments for various feature
combinations and other analysis. WW ran the OLSGW analysis for calculating
structural features. NN carried out the immunofluorescence experiments on
Drosophila embryos. KPW and CL provided conception, funding and critical
inputs. PKS prepared the datasets, designed and carried out SVM
classification experiments, interpreted results and wrote the manuscript. All
the authors read and approved the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 16 December 2010 Accepted: 21 June 2011
Published: 21 June 2011
References
1. Larsen JE, Lund O, Nielsen M: Improved method for predicting linear B-
cell epitopes. Immunome Res 2006, 2:2.
2. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR,
Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al:
Identification and analysis of functional elements in 1% of the human
genome by the ENCODE pilot project. Nature 2007, 447:799-816.
3. Celniker SE, Dillon LA, Gerstein MB, Gunsalus KC, Henikoff S, Karpen GH,
Kellis M, Lai EC, Lieb JD, MacAlpine DM, et al: Unlocking the secrets of the
genome. Nature 2009, 459:927-930.
4. Kyte J, Doolittle RF: A simple method for displaying the hydropathic
character of a protein. J Mol Biol 1982, 157:105-132.
5. Parker JM, Guo D, Hodges RS: New hydrophilicity scale derived from
high-performance liquid chromatography peptide retention data:
correlation of predicted surface residues with antigenicity and X-ray-
derived accessible sites. Biochemistry 1986, 25:5425-5432.
6. Karplus PA, Schulz GE: Flexibility scale. Naturwissenschaften 1985,
72:212-213.
7. Emini EA, Hughes JV, Perlow DS, Boger J: Induction of hepatitis A virus-
neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985,
55:836-839.
8. Wodak SJ, Janin J: Computer analysis of protein-protein interaction. J Mol
Biol 1978, 124:323-342.
9. Ponnuswamy PK, Prabhakaran M, Manavalan P: Hydrophobic packing and
spatial arrangement of amino acid residues in globular proteins. Biochim
Biophys Acta 1980, 623:301-316.
10. Pellequer JL, Westhof E, Van Regenmortel MH: Correlation between the
location of antigenic sites and the prediction of turns in proteins.
Immunol Lett 1993, 36:83-99.
11. Kolaskar AS, Tongaonkar PC: A semi-empirical method for prediction of
antigenic determinants on protein antigens. FEBS Lett 1990, 276:172-174.
12. Hopp TP, Woods KR: Prediction of protein antigenic determinants from
amino acid sequences. Proc Natl Acad Sci USA 1981, 78:3824-3828.
13. Levitt M: A simplified representation of protein conformations for rapid
simulation of protein folding. J Mol Biol 1976, 104:59-107.
14. Alix AJ: Predictive estimation of protein linear epitopes by using the
program PEOPLE. Vaccine 1999, 18:311-314.
15. Odorico M, Pellequer JL: BEPITOPE: predicting the location of continuous
epitopes and patterns in proteins. J Mol Recognit 2003, 16:20-22.
16. Saha S, Raghava GPS: BcePred: prediction of continuous B-cell epitopes
in antigenic sequences using physico-chemical properties. ICARIS 2004,
3239:197-204.
17. Blythe MJ, Flower DR: Benchmarking B cell epitope prediction:
underperformance of existing methods. Protein Sci 2005, 14:246-248.
18. Chen J, Liu H, Yang J, Chou KC: Prediction of linear B-cell epitopes using
amino acid pair antigenicity scale. Amino Acids 2007, 33:423-428.
19. Saha S, Raghava GP: Prediction of continuous B-cell epitopes in an
antigen using recurrent neural network. Proteins 2006, 65:40-48.
20. Sollner J, Mayer B: Machine learning approaches for prediction of linear
B-cell epitopes on proteins. J Mol Recognit 2006, 19:200-208.
21. El-Manzalawy Y, Dobbs D, Honavar V: Predicting linear B-cell epitopes
using string kernels. J Mol Recognit 2008, 21:243-255.
22. Sweredoski MJ, Baldi P: COBEpro: a novel system for predicting
continuous B-cell epitopes. Protein Eng Des Sel 2009, 22:113-120.
23. Kulkarni-Kale U, Bhosle S, Kolaskar AS: CEP: a conformational epitope
prediction server. Nucleic Acids Res 2005, 33:W168-171.
24. Haste Andersen P, Nielsen M, Lund O: Prediction of residues in
discontinuous B-cell epitopes using protein 3D structures. Protein Sci
2006, 15:2558-2567.
25. El-Manzalawy Y, Honavar V: Recent advances in B-cell epitope prediction
methods. Immunome Res 2010, 6(Suppl 2):S2.
26. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R,
Sette A, Peters B: The immune epitope database 2.0. Nucleic Acids Res
2010, 38:D854-862.
27. Saha S, Bhasin M, Raghava GP: Bcipep: a database of B-cell epitopes. BMC
Genomics 2005, 6:79.
28. Blythe MJ, Doytchinova IA, Flower DR: JenPep: a database of quantitative
functional peptide data for immunology. Bioinformatics 2002, 18:434-439.
29. McSparron H, Blythe MJ, Zygouri C, Doytchinova IA, Flower DR: JenPep: a
novel computational information resource for immunobiology and
vaccinology. J Chem Inf Comput Sci 2003, 43:1276-1287.
30. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M,
Zwahlen M, Kampf C, Wester K, Hober S, et al: Towards a knowledge-
based Human Protein Atlas. Nat Biotechnol 2010, 28:1248-1250.
31. Dor O, Zhou Y: Achieving 80% ten-fold cross-validated accuracy for
secondary structure prediction by large-scale training. Proteins 2007,
66:838-845.
32. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W,
Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs. Nucleic Acids Res 1997, 25:3389-3402.
33. Krogh A, Brown M, Mian IS, Sjolander K, Haussler D: Hidden Markov
models in computational biology. Applications to protein modeling.
J Mol Biol 1994, 235:1501-1531.
34. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through
sequence weighting, position-specific gap penalties and weight matrix
choice. Nucleic Acids Res 1994, 22:4673-4680.
35. Edgar RC: MUSCLE: multiple sequence alignment with high accuracy and
high throughput. Nucleic Acids Res 2004, 32:1792-1797.
36. Jones DT: Protein secondary structure prediction based on position-
specific scoring matrices. J Mol Biol 1999, 292:195-202.
Wang et al. BMC Bioinformatics 2011, 12:251
http://www.biomedcentral.com/1471-2105/12/251
Page 12 of 1337. Cheng J, Randall AZ, Sweredoski MJ, Baldi P: SCRATCH: a protein structure
and structural feature prediction server. Nucleic Acids Res 2005, 33:W72-76.
38. Vucetic S, Brown CJ, Dunker AK, Obradovic Z: Flavors of protein disorder.
Proteins 2003, 52:573-584.
39. Fiser A, Sali A: Modeller: generation and refinement of homology-based
protein structure models. Methods Enzymol 2003, 374:461-491.
40. Mulder NJ, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P,
Buillard V, Cerutti L, Copley R, et al: New developments in the InterPro
database. Nucleic Acids Res 2007, 35:D224-228.
41. Altschul SF MT, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ:
Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res 1997.
42. Wootton JC, Federhen S: Analysis of compositionally biased regions in
sequence databases. Methods Enzymol 1996, 266:554-571.
43. Rong-En Fan P-HC, Chih-Jen Lin: Working set selection using second
order information for training SVM. Journal of Machine Learning Research
2005, 6:1889-1918.
44. Joachims T: Making large-Scale SVM Learning Practical MIT-Press; 1999.
45. Schul GE: PAKa: Flexibility scale. Naturwissenschaften 1985.
46. Pellequer J-L, W E, Regenmortel MHV: Turns scale. Immunology Letter 1980.
doi:10.1186/1471-2105-12-251
Cite this article as: Wang et al.: Determinants of antigenicity and
specificity in immune response for protein sequences. BMC
Bioinformatics 2011 12:251.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wang et al. BMC Bioinformatics 2011, 12:251
http://www.biomedcentral.com/1471-2105/12/251
Page 13 of 13